Correlation Between Blueprint Medicines and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Mereo BioPharma Group, you can compare the effects of market volatilities on Blueprint Medicines and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Mereo BioPharma.
Diversification Opportunities for Blueprint Medicines and Mereo BioPharma
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Blueprint and Mereo is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Mereo BioPharma
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.9 times more return on investment than Mereo BioPharma. However, Blueprint Medicines Corp is 1.11 times less risky than Mereo BioPharma. It trades about 0.22 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.17 per unit of risk. If you would invest 8,440 in Blueprint Medicines Corp on August 24, 2024 and sell it today you would earn a total of 1,317 from holding Blueprint Medicines Corp or generate 15.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Mereo BioPharma Group
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Mereo BioPharma Group |
Blueprint Medicines and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Mereo BioPharma
The main advantage of trading using opposite Blueprint Medicines and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Blueprint Medicines vs. Lyra Therapeutics | Blueprint Medicines vs. Hookipa Pharma | Blueprint Medicines vs. Cingulate Warrants | Blueprint Medicines vs. SAB Biotherapeutics |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |